Shuji Hibiya

5PUBLICATIONS
28CO-AUTHORS
Immunogenetics (incl. genetic immunology)Pacific Peoples diet and nutritionCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract.

|Mar 28, 2026
IL-22 induces Paneth cell metaplasia in the colonic epithelium of ulcerative colitis, promoting wound healing via REG3A.

Tomohiro Muto, Go Ito, Hiromune Katsuda

|Jul 29, 2021
Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.

Kento Takenaka, Ami Kawamoto, Shuji Hibiya

|Mar 01, 2021
Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission.

Miyuki Kaneshiro, Kento Takenaka, Kohei Suzuki

|Nov 07, 2020
5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis.

Shuji Hibiya, Yusuke Matsuyama, Toshimitsu Fujii

Pageof 1

Frequent Collaborators

4 joint publications

Ryuichi Okamoto

3 joint publications

Kento Takenaka

3 joint publications

Toshimitsu Fujii

3 joint publications

Ami Kawamoto